$9.90
-1.24-11.09%
At close: -
$10.37
0.464.69%
After Hours: 7:15 PM EDT
Comments
Loading...
Immunome (IMNM) Forecast
NewsEarningsImmunome (IMNM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestImmunome (NASDAQ:IMNM) Stock Quotes, Forecast and News Summary
Immunome Stock (NASDAQ: IMNM) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immunome (IMNM) stock?
You can purchase shares of Immunome (NASDAQ:IMNM) through any online brokerage.
Who are Immunome (IMNM) competitors?
Other companies in Immunome’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Replimune Group (NASDAQ:REPL), Altimmune (NASDAQ:ALT) and AnaptysBio (NASDAQ:ANAB).
What is the forecast, or price target, for Immunome (IMNM) stock?
Immunome has a consensus price target of $22.71.
What is the current price for Immunome (IMNM)?
The stock price for Immunome (NASDAQ: IMNM) is $10.37 last updated November 15, 2024 at 7:15 PM EST.
Does Immunome (IMNM) pay a dividend?
There are no upcoming dividends for Immunome.
When is Immunome (NASDAQ:IMNM) reporting earnings?
Immunome’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Immunome (IMNM) going to split?
There is no upcoming split for Immunome.
What sector and industry does Immunome (IMNM) operate in?
Immunome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.